Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Hkins552
    Member
    • Jun 2011
    • 18

    samtools view error after reheader

    I am currently having an issue with samtools view for conversion of .sam to .bam. After replacing the header of my .sam in order to match the ref contigs I think attempted the conversion and received the following output:

    $ samtools view -bS 1112-1.reheader.sam > 1112-1.reheader.bam

    [sam_read1] reference 'chr1' is recognized as '*'.
    [sam_read1] reference 'chr1' is recognized as '*'.
    [sam_read1] reference 'chr1' is recognized as '*'.
    etc.

    Basically for an endless number of lines.

    Has anyone seen a similar error?
  • pasta
    Member
    • Jan 2011
    • 27

    #2
    Maybe this can help: http://seqanswers.com/forums/showthread.php?t=4719

    Comment

    • jjpurwar
      Junior Member
      • Jun 2011
      • 9

      #3
      Hi - I received the same error. I also reheadered my sam file and then tried to convert to a bam and received the [sam_read1] reference 'chrX' is recognized as '*'.

      Did you ever figure out a solution to the problem?

      I noticed that samtools did write a bam file. So, I visualized it (after sorting and indexing it) and it appears that the rest of the chromosomes did convert except for the chrX. I have no reads there. Not surprising.

      Comment

      • jjpurwar
        Junior Member
        • Jun 2011
        • 9

        #4
        I figured out the solution to my problem. Turns out that my sam file header had to be in the right format:

        The first line needs to be header.
        The second line needs to be a dummy read group line
        The next lines need to contain the chromosomes and their lengths.

        An example of a good header is as follows:

        @HD VN:1.0 SO:unsorted
        @RG ID:unknownReadGroup SM:unknownSample
        @SQ SN:chrI AS:ce6_32r_index LN:15072421
        @SQ SN:chrII AS:ce6_32r_index LN:15279323
        @SQ SN:chrIII AS:ce6_32r_index LN:13783681
        @SQ SN:chrIV AS:ce6_32r_index LN:17493785
        @SQ SN:chrM AS:ce6_32r_index LN:13794
        @SQ SN:chrV AS:ce6_32r_index LN:20919568
        @SQ SN:chrX AS:ce6_32r_index LN:17718854

        Once I deleted all the @SQ , @PG, @HD lines from my sam file and appended the above header text file to my sam file and tried to convert it to a bam - it worked beautifully.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...